SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $105,000 | -98.8% | 11,127 | -99.2% | 0.00% | -98.9% |
| Q1 2020 | $8,683,000 | +215.1% | 1,363,039 | +313.9% | 0.09% | +357.9% |
| Q4 2019 | $2,756,000 | +840.6% | 329,326 | +917.8% | 0.02% | +850.0% |
| Q3 2019 | $293,000 | -96.4% | 32,358 | -95.5% | 0.00% | -97.6% |
| Q4 2018 | $8,181,000 | +1678.5% | 712,657 | +2526.2% | 0.08% | +4100.0% |
| Q3 2018 | $460,000 | -9.3% | 27,136 | -51.8% | 0.00% | -90.9% |
| Q2 2017 | $507,000 | – | 56,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |